Optimal strategies for COVID-19 prevention from global evidence achieved through social distancing, stay at home, travel restriction and lockdown: a systematic review

Background Coronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but prevention strategies can alter the pandemic. However, the effectiveness of existing preventive measures and strategies is inconclusive. Therefore, this stu...

Full description

Saved in:
Bibliographic Details
Published inArchives of public health = Archives belges de santé publique Vol. 79; no. 1; pp. 1 - 18
Main Authors Girum, Tadele, Lentiro, Kifle, Geremew, Mulugeta, Migora, Biru, Shewamare, Sisay, Shimbre, Mulugeta Shegaze
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 21.08.2021
BioMed Central
BMC
Subjects
Online AccessGet full text
ISSN2049-3258
0778-7367
2049-3258
DOI10.1186/s13690-021-00663-8

Cover

Loading…
Abstract Background Coronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but prevention strategies can alter the pandemic. However, the effectiveness of existing preventive measures and strategies is inconclusive. Therefore, this study aimed to review evidence related to COVID-19 prevention achieved through social distancing, stay at home, travel ban and lockdown in order to determine best practices. Methods/design This review has been conducted in accordance with the PRISMA and Cochrane guideline. A systematic literature search of articles archived from major medical databases (MEDLINE, SCOPUS, CINAHL, PsycINFO, and Web of Science) and Google scholar was done. Observational and modeling researches published to date with information on COVID-19 prevention like social distancing, stay at home, travel ban and lockdown were included. The articles were screened by two experts. Risk of bias of included studies was assessed through ROBINS-I tool and the certainty of evidence was graded using the GRADE approach for the main outcomes. The findings were presented by narration and in tabular form. Results A total of 25 studies was included in the review. The studies consistently reported the benefit of social distancing, stay at home, travel restriction and lockdown measures. Mandatory social distancing reduced the daily growth rate by 9.1%, contacts by 7-9 folds, median number of infections by 92% and epidemic resolved in day 90. Travel restriction and lockdown averted 70.5% of exported cases in china and doubling time was increased from 2 to 4 days. It reduced contacts by 80% and decreased the initial R.sub.0, and the number of infected individuals decreased by 91.14%. Stay at home was associated with a 48.6 and 59.8% reduction in weekly morbidity and fatality. Obligatory, long term and early initiated programs were more effective. Conclusion Social distancing, stay at home, travel restriction and lockdown are effective to COVID-19 prevention. The strategies need to be obligatory, initiated early, implemented in large scale, and for a longer period of time. Combinations of the programs are more effective. However, the income of individuals should be guaranteed and supported. Keywords: COVID-19, Social distancing, Stay at home, Travel restriction and lockdown
AbstractList Background Coronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but prevention strategies can alter the pandemic. However, the effectiveness of existing preventive measures and strategies is inconclusive. Therefore, this study aimed to review evidence related to COVID-19 prevention achieved through social distancing, stay at home, travel ban and lockdown in order to determine best practices. Methods/design This review has been conducted in accordance with the PRISMA and Cochrane guideline. A systematic literature search of articles archived from major medical databases (MEDLINE, SCOPUS, CINAHL, PsycINFO, and Web of Science) and Google scholar was done. Observational and modeling researches published to date with information on COVID-19 prevention like social distancing, stay at home, travel ban and lockdown were included. The articles were screened by two experts. Risk of bias of included studies was assessed through ROBINS-I tool and the certainty of evidence was graded using the GRADE approach for the main outcomes. The findings were presented by narration and in tabular form. Results A total of 25 studies was included in the review. The studies consistently reported the benefit of social distancing, stay at home, travel restriction and lockdown measures. Mandatory social distancing reduced the daily growth rate by 9.1%, contacts by 7-9 folds, median number of infections by 92% and epidemic resolved in day 90. Travel restriction and lockdown averted 70.5% of exported cases in china and doubling time was increased from 2 to 4 days. It reduced contacts by 80% and decreased the initial R.sub.0, and the number of infected individuals decreased by 91.14%. Stay at home was associated with a 48.6 and 59.8% reduction in weekly morbidity and fatality. Obligatory, long term and early initiated programs were more effective. Conclusion Social distancing, stay at home, travel restriction and lockdown are effective to COVID-19 prevention. The strategies need to be obligatory, initiated early, implemented in large scale, and for a longer period of time. Combinations of the programs are more effective. However, the income of individuals should be guaranteed and supported. Keywords: COVID-19, Social distancing, Stay at home, Travel restriction and lockdown
Background Coronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but prevention strategies can alter the pandemic. However, the effectiveness of existing preventive measures and strategies is inconclusive. Therefore, this study aimed to review evidence related to COVID-19 prevention achieved through social distancing, stay at home, travel ban and lockdown in order to determine best practices. Methods/design This review has been conducted in accordance with the PRISMA and Cochrane guideline. A systematic literature search of articles archived from major medical databases (MEDLINE, SCOPUS, CINAHL, PsycINFO, and Web of Science) and Google scholar was done. Observational and modeling researches published to date with information on COVID-19 prevention like social distancing, stay at home, travel ban and lockdown were included. The articles were screened by two experts. Risk of bias of included studies was assessed through ROBINS-I tool and the certainty of evidence was graded using the GRADE approach for the main outcomes. The findings were presented by narration and in tabular form. Results A total of 25 studies was included in the review. The studies consistently reported the benefit of social distancing, stay at home, travel restriction and lockdown measures. Mandatory social distancing reduced the daily growth rate by 9.1%, contacts by 7–9 folds, median number of infections by 92% and epidemic resolved in day 90. Travel restriction and lockdown averted 70.5% of exported cases in china and doubling time was increased from 2 to 4 days. It reduced contacts by 80% and decreased the initial R0, and the number of infected individuals decreased by 91.14%. Stay at home was associated with a 48.6 and 59.8% reduction in weekly morbidity and fatality. Obligatory, long term and early initiated programs were more effective. Conclusion Social distancing, stay at home, travel restriction and lockdown are effective to COVID-19 prevention. The strategies need to be obligatory, initiated early, implemented in large scale, and for a longer period of time. Combinations of the programs are more effective. However, the income of individuals should be guaranteed and supported.
Coronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but prevention strategies can alter the pandemic. However, the effectiveness of existing preventive measures and strategies is inconclusive. Therefore, this study aimed to review evidence related to COVID-19 prevention achieved through social distancing, stay at home, travel ban and lockdown in order to determine best practices. This review has been conducted in accordance with the PRISMA and Cochrane guideline. A systematic literature search of articles archived from major medical databases (MEDLINE, SCOPUS, CINAHL, PsycINFO, and Web of Science) and Google scholar was done. Observational and modeling researches published to date with information on COVID-19 prevention like social distancing, stay at home, travel ban and lockdown were included. The articles were screened by two experts. Risk of bias of included studies was assessed through ROBINS-I tool and the certainty of evidence was graded using the GRADE approach for the main outcomes. The findings were presented by narration and in tabular form. A total of 25 studies was included in the review. The studies consistently reported the benefit of social distancing, stay at home, travel restriction and lockdown measures. Mandatory social distancing reduced the daily growth rate by 9.1%, contacts by 7-9 folds, median number of infections by 92% and epidemic resolved in day 90. Travel restriction and lockdown averted 70.5% of exported cases in china and doubling time was increased from 2 to 4 days. It reduced contacts by 80% and decreased the initial R.sub.0, and the number of infected individuals decreased by 91.14%. Stay at home was associated with a 48.6 and 59.8% reduction in weekly morbidity and fatality. Obligatory, long term and early initiated programs were more effective. Social distancing, stay at home, travel restriction and lockdown are effective to COVID-19 prevention. The strategies need to be obligatory, initiated early, implemented in large scale, and for a longer period of time. Combinations of the programs are more effective. However, the income of individuals should be guaranteed and supported.
Abstract Background Coronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but prevention strategies can alter the pandemic. However, the effectiveness of existing preventive measures and strategies is inconclusive. Therefore, this study aimed to review evidence related to COVID-19 prevention achieved through social distancing, stay at home, travel ban and lockdown in order to determine best practices. Methods/design This review has been conducted in accordance with the PRISMA and Cochrane guideline. A systematic literature search of articles archived from major medical databases (MEDLINE, SCOPUS, CINAHL, PsycINFO, and Web of Science) and Google scholar was done. Observational and modeling researches published to date with information on COVID-19 prevention like social distancing, stay at home, travel ban and lockdown were included. The articles were screened by two experts. Risk of bias of included studies was assessed through ROBINS-I tool and the certainty of evidence was graded using the GRADE approach for the main outcomes. The findings were presented by narration and in tabular form. Results A total of 25 studies was included in the review. The studies consistently reported the benefit of social distancing, stay at home, travel restriction and lockdown measures. Mandatory social distancing reduced the daily growth rate by 9.1%, contacts by 7–9 folds, median number of infections by 92% and epidemic resolved in day 90. Travel restriction and lockdown averted 70.5% of exported cases in china and doubling time was increased from 2 to 4 days. It reduced contacts by 80% and decreased the initial R0, and the number of infected individuals decreased by 91.14%. Stay at home was associated with a 48.6 and 59.8% reduction in weekly morbidity and fatality. Obligatory, long term and early initiated programs were more effective. Conclusion Social distancing, stay at home, travel restriction and lockdown are effective to COVID-19 prevention. The strategies need to be obligatory, initiated early, implemented in large scale, and for a longer period of time. Combinations of the programs are more effective. However, the income of individuals should be guaranteed and supported.
Coronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but prevention strategies can alter the pandemic. However, the effectiveness of existing preventive measures and strategies is inconclusive. Therefore, this study aimed to review evidence related to COVID-19 prevention achieved through social distancing, stay at home, travel ban and lockdown in order to determine best practices.BACKGROUNDCoronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but prevention strategies can alter the pandemic. However, the effectiveness of existing preventive measures and strategies is inconclusive. Therefore, this study aimed to review evidence related to COVID-19 prevention achieved through social distancing, stay at home, travel ban and lockdown in order to determine best practices.This review has been conducted in accordance with the PRISMA and Cochrane guideline. A systematic literature search of articles archived from major medical databases (MEDLINE, SCOPUS, CINAHL, PsycINFO, and Web of Science) and Google scholar was done. Observational and modeling researches published to date with information on COVID-19 prevention like social distancing, stay at home, travel ban and lockdown were included. The articles were screened by two experts. Risk of bias of included studies was assessed through ROBINS-I tool and the certainty of evidence was graded using the GRADE approach for the main outcomes. The findings were presented by narration and in tabular form.METHODS/DESIGNThis review has been conducted in accordance with the PRISMA and Cochrane guideline. A systematic literature search of articles archived from major medical databases (MEDLINE, SCOPUS, CINAHL, PsycINFO, and Web of Science) and Google scholar was done. Observational and modeling researches published to date with information on COVID-19 prevention like social distancing, stay at home, travel ban and lockdown were included. The articles were screened by two experts. Risk of bias of included studies was assessed through ROBINS-I tool and the certainty of evidence was graded using the GRADE approach for the main outcomes. The findings were presented by narration and in tabular form.A total of 25 studies was included in the review. The studies consistently reported the benefit of social distancing, stay at home, travel restriction and lockdown measures. Mandatory social distancing reduced the daily growth rate by 9.1%, contacts by 7-9 folds, median number of infections by 92% and epidemic resolved in day 90. Travel restriction and lockdown averted 70.5% of exported cases in china and doubling time was increased from 2 to 4 days. It reduced contacts by 80% and decreased the initial R0, and the number of infected individuals decreased by 91.14%. Stay at home was associated with a 48.6 and 59.8% reduction in weekly morbidity and fatality. Obligatory, long term and early initiated programs were more effective.RESULTSA total of 25 studies was included in the review. The studies consistently reported the benefit of social distancing, stay at home, travel restriction and lockdown measures. Mandatory social distancing reduced the daily growth rate by 9.1%, contacts by 7-9 folds, median number of infections by 92% and epidemic resolved in day 90. Travel restriction and lockdown averted 70.5% of exported cases in china and doubling time was increased from 2 to 4 days. It reduced contacts by 80% and decreased the initial R0, and the number of infected individuals decreased by 91.14%. Stay at home was associated with a 48.6 and 59.8% reduction in weekly morbidity and fatality. Obligatory, long term and early initiated programs were more effective.Social distancing, stay at home, travel restriction and lockdown are effective to COVID-19 prevention. The strategies need to be obligatory, initiated early, implemented in large scale, and for a longer period of time. Combinations of the programs are more effective. However, the income of individuals should be guaranteed and supported.CONCLUSIONSocial distancing, stay at home, travel restriction and lockdown are effective to COVID-19 prevention. The strategies need to be obligatory, initiated early, implemented in large scale, and for a longer period of time. Combinations of the programs are more effective. However, the income of individuals should be guaranteed and supported.
ArticleNumber 150
Audience Academic
Author Shimbre, Mulugeta Shegaze
Shewamare, Sisay
Girum, Tadele
Lentiro, Kifle
Geremew, Mulugeta
Migora, Biru
Author_xml – sequence: 1
  givenname: Tadele
  surname: Girum
  fullname: Girum, Tadele
– sequence: 2
  givenname: Kifle
  surname: Lentiro
  fullname: Lentiro, Kifle
– sequence: 3
  givenname: Mulugeta
  surname: Geremew
  fullname: Geremew, Mulugeta
– sequence: 4
  givenname: Biru
  surname: Migora
  fullname: Migora, Biru
– sequence: 5
  givenname: Sisay
  surname: Shewamare
  fullname: Shewamare, Sisay
– sequence: 6
  givenname: Mulugeta Shegaze
  orcidid: 0000-0001-5633-1309
  surname: Shimbre
  fullname: Shimbre, Mulugeta Shegaze
BookMark eNp9ks2O0zAUhSM0iPmBF2BlCQmxmAy2E9sxC6RR-as0UjfA1nIdO3FJ7GKnHc0L8ZzctoOYjhDKwtHNd8-9OT7nxUmIwRbFS4KvCGn420wqLnGJKSkx5rwqmyfFGcW1LCvKmpMH76fFec4rjKmEyrPitKprIknNzopfi_XkRz2gPCU92c7bjFxMaLb4Pv9QEonWyW5tmHwMyKU4om6IS8Dt1rc2GIu06T0QLZr6FDddj3I0HoDW50kH40N3Cdr6DukJ9XG0lwgGbe2AkoWR3uyVdWjREM2PNt6Gd0ijfJcnO-rJG8C23t4-L546PWT74v68KL59-vh19qW8WXyez65vSsMEmUohNaZsybhrsHbOtVJUZtlUFcesYUI0beWEw7iqas4olpxIzJwQknHGheHVRTE_6LZRr9Q6gTXpTkXt1b4QU6d0grUGq6RxWGhDCGHLWtZMWqrrFnNjLW9AG7TeH7TWm-VoWwMuJj0ciR5_Cb5XXdyqpmowwbtl3twLpPhzA3ap0Wdjh0EHGzdZUcYhAEIQDOirR-gqblIAq4ASlFEKKfhLdRp-wAcXYa7ZiaprLhglsuYUqKt_UPC0dvQGIug81I8aXj9o6K0epj7HYbO72nwMNgfQpJhzsk4ZP-kdBhP8oAhWu2CrQ7AVBFvtg612q9NHrX98_E_Tb2Iy-nM
CitedBy_id crossref_primary_10_1007_s13762_024_05610_y
crossref_primary_10_1080_21645515_2023_2276624
crossref_primary_10_1128_jcm_00612_23
crossref_primary_10_1016_j_jpra_2022_07_002
crossref_primary_10_1515_med_2023_0674
crossref_primary_10_2196_50303
crossref_primary_10_1186_s12889_022_14574_y
crossref_primary_10_3390_jcm11247275
crossref_primary_10_3389_fpubh_2023_1037496
crossref_primary_10_3390_healthcare11081191
crossref_primary_10_1111_1745_5871_12561
crossref_primary_10_3390_children12020178
crossref_primary_10_7759_cureus_50320
crossref_primary_10_1002_cl2_1336
crossref_primary_10_1002_cl2_1219
crossref_primary_10_1080_10410236_2024_2413762
crossref_primary_10_4103_aihb_aihb_53_23
crossref_primary_10_1016_j_heliyon_2023_e13879
crossref_primary_10_54393_pjhs_v4i11_821
crossref_primary_10_1002_cl2_1421
crossref_primary_10_1186_s12879_024_09007_7
crossref_primary_10_1080_08164622_2024_2388125
crossref_primary_10_3390_healthcare11142101
crossref_primary_10_3390_jcm13164766
crossref_primary_10_1093_jtm_taac081
crossref_primary_10_1111_nyas_14947
crossref_primary_10_1080_09540121_2022_2049197
crossref_primary_10_1186_s41182_024_00603_6
crossref_primary_10_4103_aihb_aihb_60_22
crossref_primary_10_1002_cl2_1422
crossref_primary_10_3390_life15030355
crossref_primary_10_3390_vaccines10122141
crossref_primary_10_3390_vaccines11071195
crossref_primary_10_3390_epidemiologia6010006
crossref_primary_10_3390_healthcare11030288
crossref_primary_10_3390_populations1010005
crossref_primary_10_1002_asi_24893
crossref_primary_10_1007_s00431_022_04682_7
crossref_primary_10_12968_jpar_2023_15_2_74
crossref_primary_10_1016_j_jhin_2022_09_001
crossref_primary_10_2147_IDR_S369266
crossref_primary_10_1371_journal_pone_0293722
crossref_primary_10_1186_s12879_024_09136_z
crossref_primary_10_3346_jkms_2022_37_e129
crossref_primary_10_1016_j_lanwpc_2022_100581
crossref_primary_10_1002_cesm_12055
crossref_primary_10_1177_00469580231175437
crossref_primary_10_4266_acc_2024_00654
crossref_primary_10_1186_s12889_022_14567_x
crossref_primary_10_1002_cl2_1442
crossref_primary_10_1007_s10238_023_01188_w
crossref_primary_10_1007_s10389_024_02230_1
crossref_primary_10_3390_vaccines10101631
crossref_primary_10_1016_j_knosys_2025_113065
crossref_primary_10_1016_S0140_6736_22_01585_9
Cites_doi 10.1371/journal.pone.0233744
10.1101/2020.04.13.20063628
10.20944/preprints202005.0201.v1
10.1016/S2468-2667(20)30073-6
10.2139/ssrn.3577213
10.3390/jcm9020462
10.1007/s11538-020-00726-x
10.1093/oxrep/graa033
10.1186/2046-4053-4-1
10.1016/j.envint.2016.01.004
10.1056/NEJMoa2002032
10.1136/bmj.i4919
10.1016/j.ijinfomgt.2020.102182
10.1056/NEJMe2005477
10.21037/jtd.2020.02.64
10.1101/2020.03.22.20041079
10.1101/2020.03.28.20046110
10.1038/s41562-020-0898-6
10.1101/2020.03.19.20039107
10.1002/pad.1891
10.1016/S0140-6736(20)31142-9
10.1101/2020.03.29.20046870
10.1016/S2213-2600(20)30076-X
10.1101/2020.04.13.20063933
10.1101/2020.05.07.20092353
10.1056/NEJMoa2001282
10.1016/S0140-6736(20)30183-5
10.1126/science.aba9757
10.1073/pnas.2002616117
10.1101/2020.03.02.20026708
10.1016/j.jcv.2020.104440
10.1093/jtm/taaa037
10.1016/S0140-6736(20)30154-9
10.1017/dmp.2021.9
10.1186/s41182-020-00285-w
10.1377/hlthaff.2020.00608
10.1002/9781119536604
10.2139/ssrn.3576703
10.1002/14651858.CD013574
10.1101/2020.04.23.20077024
10.1177/0272989X12454577
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021. The Author(s).
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021. The Author(s).
– notice: The Author(s) 2021
DBID AAYXX
CITATION
8C1
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13690-021-00663-8
DatabaseName CrossRef
Public Health Database
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Public Health
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Central
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database



MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 2049-3258
EndPage 18
ExternalDocumentID oai_doaj_org_article_9cf07ac1115b49459e2a4d06cee68209
PMC8380106
A675219462
10_1186_s13690_021_00663_8
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID 0R~
2WC
2XV
4.4
5VS
8C1
AAFWJ
AAJSJ
AASML
AAYXX
ABUWG
ACGFS
ADBBV
ADRAZ
ADUKV
AEUYN
AFKRA
AFPKN
AHBYD
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
C6C
CCPQU
CITATION
DIK
EBLON
EBS
ECGQY
EIHBH
FYUFA
GROUPED_DOAJ
HYE
IAO
IHR
IHW
ITC
KQ8
M48
M~E
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
UKHRP
W2D
XSB
PMFND
AZQEC
COVID
DWQXO
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c571t-79a025b56f80afffd973cb83360585778d3f7f003346520961905f77956567c63
IEDL.DBID M48
ISSN 2049-3258
0778-7367
IngestDate Wed Aug 27 01:31:25 EDT 2025
Thu Aug 21 14:12:28 EDT 2025
Tue Aug 05 09:58:39 EDT 2025
Fri Jul 25 09:21:10 EDT 2025
Tue Jun 17 21:03:12 EDT 2025
Tue Jun 10 20:36:12 EDT 2025
Thu May 22 21:20:19 EDT 2025
Thu Apr 24 22:52:49 EDT 2025
Tue Jul 01 02:18:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c571t-79a025b56f80afffd973cb83360585778d3f7f003346520961905f77956567c63
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0001-5633-1309
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13690-021-00663-8
PMID 34419145
PQID 2572522258
PQPubID 4665242
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_9cf07ac1115b49459e2a4d06cee68209
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8380106
proquest_miscellaneous_2563697710
proquest_journals_2572522258
gale_infotracmisc_A675219462
gale_infotracacademiconefile_A675219462
gale_healthsolutions_A675219462
crossref_citationtrail_10_1186_s13690_021_00663_8
crossref_primary_10_1186_s13690_021_00663_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-08-21
PublicationDateYYYYMMDD 2021-08-21
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-21
  day: 21
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Archives of public health = Archives belges de santé publique
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References A Brodeur (663_CR21) 2020
K Prem (663_CR34) 2020; 5
663_CR40
JAC Sterne (663_CR13) 2016; 355
663_CR20
663_CR42
663_CR22
M Chinazzi (663_CR27) 2020; 368
663_CR44
Y Kebede (663_CR24) 2020; 15
663_CR46
663_CR23
C Huang (663_CR6) 2020; 395
663_CR25
663_CR47
RL Morgan (663_CR15) 2016; 92–93
663_CR16
663_CR19
CR Wells (663_CR17) 2020; 117
B Tang (663_CR38) 2020; 9
Z Yang (663_CR39) 2020; 12
LR Baden (663_CR9) 2020; 382
S Eubank (663_CR35) 2020; 82
D Moher (663_CR11) 2015; 4
T Girum (663_CR41) 2020; 48
P Block (663_CR33) 2020; 4
663_CR2
W Guan (663_CR3) 2020; 382
Z Xu (663_CR8) 2020; 8
663_CR1
663_CR4
E Ekienabor (663_CR26) 2020
663_CR30
663_CR10
663_CR32
663_CR12
JJ Caro (663_CR14) 2012; 32
S Kissler (663_CR31) 2020
663_CR36
663_CR28
JF Chan (663_CR7) 2020; 395
C Coombs (663_CR45) 2020; 55
H Lau (663_CR18) 2020; 27
B Cao (663_CR5) 2020; 382
DK Chu (663_CR43) 2020; S0140–6736
DM Kennedy (663_CR37) 2020; 128
W Broniec (663_CR29) 2020
References_xml – volume: 15
  start-page: e0233744
  issue: 5
  year: 2020
  ident: 663_CR24
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0233744
– ident: 663_CR25
  doi: 10.1101/2020.04.13.20063628
– start-page: 2020050201
  volume-title: Coronavirus (Covid-19): The Lockdown Strategy in Nigeria
  year: 2020
  ident: 663_CR26
  doi: 10.20944/preprints202005.0201.v1
– volume: 5
  start-page: e261
  issue: 5
  year: 2020
  ident: 663_CR34
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(20)30073-6
– ident: 663_CR19
  doi: 10.2139/ssrn.3577213
– volume: 9
  start-page: 462
  issue: 2
  year: 2020
  ident: 663_CR38
  publication-title: J Clin Med
  doi: 10.3390/jcm9020462
– volume: 82
  start-page: 52
  issue: 4
  year: 2020
  ident: 663_CR35
  publication-title: Bull Math Biol
  doi: 10.1007/s11538-020-00726-x
– ident: 663_CR46
  doi: 10.1093/oxrep/graa033
– volume: 4
  start-page: 1
  issue: 1
  year: 2015
  ident: 663_CR11
  publication-title: Syst Rev
  doi: 10.1186/2046-4053-4-1
– volume: 92–93
  start-page: 611
  year: 2016
  ident: 663_CR15
  publication-title: Environ Int
  doi: 10.1016/j.envint.2016.01.004
– volume: 382
  start-page: 1708
  issue: 18
  year: 2020
  ident: 663_CR3
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2002032
– volume: 355
  start-page: i4919
  year: 2016
  ident: 663_CR13
  publication-title: BMJ
  doi: 10.1136/bmj.i4919
– volume: 55
  start-page: 102182
  year: 2020
  ident: 663_CR45
  publication-title: Int J Inf Manag
  doi: 10.1016/j.ijinfomgt.2020.102182
– volume: 382
  start-page: 1851
  issue: 19
  year: 2020
  ident: 663_CR9
  publication-title: N Engl J Med
  doi: 10.1056/NEJMe2005477
– volume: 12
  start-page: 165
  issue: 3
  year: 2020
  ident: 663_CR39
  publication-title: J Thorac Dis
  doi: 10.21037/jtd.2020.02.64
– ident: 663_CR1
– start-page: 13255
  volume-title: IZA DP
  year: 2020
  ident: 663_CR21
– volume-title: Social distancing strategies for curbing the COVID-19 epidemic
  year: 2020
  ident: 663_CR31
  doi: 10.1101/2020.03.22.20041079
– ident: 663_CR23
  doi: 10.1101/2020.03.28.20046110
– volume: 4
  start-page: 588
  issue: 6
  year: 2020
  ident: 663_CR33
  publication-title: Nat Hum Behav
  doi: 10.1038/s41562-020-0898-6
– ident: 663_CR30
  doi: 10.1101/2020.03.19.20039107
– ident: 663_CR47
  doi: 10.1002/pad.1891
– volume: S0140–6736
  start-page: 31142
  issue: 20
  year: 2020
  ident: 663_CR43
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)31142-9
– ident: 663_CR32
  doi: 10.1101/2020.03.29.20046870
– volume: 8
  start-page: 420
  issue: 4
  year: 2020
  ident: 663_CR8
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30076-X
– ident: 663_CR40
  doi: 10.1101/2020.04.13.20063933
– ident: 663_CR20
  doi: 10.1101/2020.05.07.20092353
– volume: 382
  start-page: 1787
  issue: 19
  year: 2020
  ident: 663_CR5
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2001282
– volume-title: Using VERA to explain the impact of social distancing on the spread of COVID-19
  year: 2020
  ident: 663_CR29
– volume: 395
  start-page: 497
  issue: 10223
  year: 2020
  ident: 663_CR6
  publication-title: China Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 368
  start-page: 395
  issue: 6489
  year: 2020
  ident: 663_CR27
  publication-title: Science
  doi: 10.1126/science.aba9757
– volume: 117
  start-page: 7504
  issue: 13
  year: 2020
  ident: 663_CR17
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2002616117
– ident: 663_CR16
  doi: 10.1101/2020.03.02.20026708
– volume: 128
  start-page: 104440
  year: 2020
  ident: 663_CR37
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2020.104440
– volume: 27
  start-page: taaa037
  issue: 3
  year: 2020
  ident: 663_CR18
  publication-title: J Travel Med
  doi: 10.1093/jtm/taaa037
– ident: 663_CR2
– volume: 395
  start-page: 514
  issue: 10223
  year: 2020
  ident: 663_CR7
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30154-9
– ident: 663_CR4
– ident: 663_CR44
  doi: 10.1017/dmp.2021.9
– volume: 48
  start-page: 91
  issue: 1
  year: 2020
  ident: 663_CR41
  publication-title: Trop Med Health
  doi: 10.1186/s41182-020-00285-w
– ident: 663_CR22
  doi: 10.1377/hlthaff.2020.00608
– ident: 663_CR12
  doi: 10.1002/9781119536604
– ident: 663_CR28
  doi: 10.2139/ssrn.3576703
– ident: 663_CR10
– ident: 663_CR42
  doi: 10.1002/14651858.CD013574
– ident: 663_CR36
  doi: 10.1101/2020.04.23.20077024
– volume: 32
  start-page: 667
  issue: 5
  year: 2012
  ident: 663_CR14
  publication-title: Med Decis Mak
  doi: 10.1177/0272989X12454577
SSID ssj0029049
Score 2.4542284
SecondaryResourceType review_article
Snippet Background Coronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but prevention...
Coronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but prevention strategies can...
Abstract Background Coronavirus disease (COVID-19) is a global public health agenda with high level of pandemicity. There is no effective treatment, but...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 1
SubjectTerms Analysis
Asymptomatic
Bans
China
Coronaviruses
COVID-19
Disease prevention
Epidemics
Health aspects
Infections
Medical research
Pandemics
Prevention
Public health
Respiratory diseases
Sanctions (International law)
Severe acute respiratory syndrome coronavirus 2
Social distancing
Stay at home
Subject heading schemes
Systematic Review
Travel
Travel restriction and lockdown
Travel restrictions
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9UwELZQT0gIsYpAC4OExIFGfVm8cSuFqiBBLxT1ZjmOrVa0eVVfeuAP9XcyYzuPBiS4cI0nUewZz2LPfMPYq85pJVQfSh-4p2tGWyq-sGVtO95zH6wPVI38-Ys4OGo_HfPjG62-KCcswQOnhdvRLiykdbgledfqlmtf27ZfCFTuAq1XLN1DmzcFUznU0uj4TiUySuysqgajwJLSEaKNLdXMDEW0_j918u95kjcMz_49djd7jLCb_vQ-u-WHB-xOOm6DVEX0kF0f4tY_R7LVOGE_ALqjsHf47eP7stJwkaGalgNQRQkkIBDwuakoUE4lUvSQG_dAOkyHnvzLwaGB28Zv2x9gRzhZnvttGKlx0RlQb4_L01gdAXboAY3j9x5D-7dg4RdMNKQSmUfsaP_D172DMrdgKB2X1VhKbdEp6rgIamFDCL2WjetU09BtKpdS9U2QgRrCtYISajAcW_AgpSY_UTrRPGYbw3LwTxjUrhauqwR3VD-lRdfRnTe6N7LxFp2YglUTR4zL-OTUJuPMxDhFCZO4aJCLJnLRqIK9Wb9zkdA5_kr9jhi9piRk7fgA5c1keTP_kreCvSAxMalMda0fzC5GXqj9W1EX7HWkIA2BE3A2FzrgMhDW1oxyc0aJO9vNhydRNFmzrAyq2JpTkI7TebkepjcpW27wyyuiETh3ic5jweRMhGdzn48MpycRXVw1is4Jnv6PxXrGbtdx06E2rjbZxnh55bfQiRu753G__gTUtUQs
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZge0FCiKcILTBISBxo1M3DLy6oLa0KEi1CFPVmOY5NK9pku5se-EP8TmYS75aA1Gs82cg7nplvxvNg7HXltBKqDqkP3NM1o00Vn9o0txWvuQ_WB6pG_nwoDo7LTyf8JAbcFjGtcqkTe0Vdt45i5Ft4tHJOzol6P7tMaWoU3a7GERq32RqqYMUnbG1n7_DL15XLpREAL0tllNhaZAV6gymlJfS2NlUjc9R37f9fN_-bL_mXAdq_z-5F5AjbA6sfsFu-ecjuDmE3GKqJHrHfR6gCLpBs0S17QADCUtg9-v7xQ5ppmMWWTW0DVFkCQ0MQ8HG4KFBuJVLUEAf4wBBUh5pwZuPQ0G3ib9tfYDs4bS_8JnQ0wOgcaMbH_KyvkgDb1IBG8meNLv47sHDdLhqGUpnH7Hh_79vuQRpHMaSOy6xLpbYIjiougpraEEKtZeEqVRR0q8qlVHURZKDBcKWgxBp0y6Y8SKkJL0oniids0rSNf8ogd7lwVSa4ozoqLaqK7r4R5sjCWwQzCcuWHDEu9imncRnnpvdXlDADFw1y0fRcNCphb1fvzIYuHTdS7xCjV5TUYbt_0M5_mCiwRrswldahKeBVqUuufW7LeioQVAhETTphL-mYmKFcdaUnzDZ6YGgFSpEn7E1PQZoCN-BsLHjAv4F6bo0oN0aUKOFuvLw8iiZqmIW5loeEvVot05uUNdf49opoBO5dIohMmBwd4dHexyvN2WnfZVwViuIFz27--Dq7k_fihPo222CTbn7lnyNM66oXURb_AM37PVM
  priority: 102
  providerName: ProQuest
Title Optimal strategies for COVID-19 prevention from global evidence achieved through social distancing, stay at home, travel restriction and lockdown: a systematic review
URI https://www.proquest.com/docview/2572522258
https://www.proquest.com/docview/2563697710
https://pubmed.ncbi.nlm.nih.gov/PMC8380106
https://doaj.org/article/9cf07ac1115b49459e2a4d06cee68209
Volume 79
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3raxQxEA99fBFEfOJpPSMIfrCr-8pLELmeLfWgragn_Ray2cQWr3v1bgv2H_LvdCa7e7pa-ulgM9kjOzOZ3yTzIOR5YZXksvSR88zhNaOJJItNlJqClcx54zxmIx8c8v1pPjlmx2uka3fUfsDlla4d9pOaLmavfv64fAcK_zYovOSvl0kGPl6EwQbBgkZynWyCZeIo5Qf56lYhVQCHu8SZK-f1jFOo4f__Tv1v9ORf5mjvNrnV4kg6ahh_h6y56i652RzC0Sa36B75dQQbwhmQLeuuIgQFkErHR18_vI8SRc_bAk7zimKeCW3Kg1DXthqlGGkJFCVt2_nQ5oidlog6KwtmbxvebS6pqenJ_Mxt0xrbGc0odvxYnIacCWqqkoLJ_F6Cw_-GGvqneDRtEmfuk-ne7pfxftQ2ZogsE0kdCWUAKhWMexkb732pRGYLmWV4x8qEkGXmhcc2cTnHMBtw0mLmhVCIHoXl2QOyUc0r95DQ1KbcFglnFrOqFC8KvAkH0CMyZwDaDEjScUTbtmo5Ns-Y6eC9SK4bLmrgog5c1HJAXq7mnDc1O66l3kFGryix3nZ4MF980636amV9LIwFw8CKXOVMudTkZcwBYnDAUGpAnqKY6CZ5dbVr6BH4Y2ATcp4OyItAgZIMC7CmTX-Az4AVuHqUWz1K0HfbH-5EUXfqomHjTRm67rCcZ6thnIkxdJWbXyANh7ULgJQDInoi3Ft7f6Q6PQk1x2Um8fTg0fV__pjcSIM6we6bbJGNenHhngBoq4shWZfjZEg2R6PJ5wn87uwefvw0DEcgw6ClvwEBwEQL
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELZK-wASQpwiUKiRQDzQqJvDFxJCPbWl7RahFvXNOI5NK9pk2U1V9Q_xyG9kJseWgNS3vsbjRM6MZ76x5yDkdWaV5DL3ofPM4TWjCSUbmDA2GcuZ88Z5zEbeG_HhYfrpiB3Nkd9dLgyGVXY6sVbUeWnxjHwFRCtm6JzIj-OfIXaNwtvVroVGIxY77vICXLbph-0N4O-bON7aPFgfhm1XgdAyEVWhUAbsfMa4lwPjvc-VSGwmkwQvCJkQMk-88NjjLOUYIwIexoB5IRRCH2F5Au-9RRYAZijYRQtrm6PPX2YungLA3aXmSL4yjRLwPkMMg6hteyh75q_uEvC_Lfg3PvMvg7d1n9xrkSpdbUTrAZlzxUNytznmo0320iPyax9UzhmQTauu5gQFGEzX979ub4SRouO2RFRZUMxkoU0BEuraZqYUYzmBIqdtwyDaHOLTHHFtYcGwLsO7zSU1FT0uz9wyrbBh0inFniKTkzorg5oip2CUf-TlRfGeGnpVnpo2qTmPyeGNMOkJmS_Kwj0lNLYxt1nEmcW8LcWzDO_aAVaJxBkATwGJOo5o29ZFx_Ycp7r2jyTXDRc1cFHXXNQyIO9mc8ZNVZBrqdeQ0TNKrOhdPygn33WrILSyfiCMBdPDslSlTLnYpPmAA4jhgNJUQJZQTHSTHjvTS3oVPD6wOimPA_K2pkDNBAuwpk2wgN-ANb56lIs9StAotj_ciaJuNdpUX-2_gLyaDeNMjNIrXHmONBzWLgC0BkT0RLi39v5IcXJcVzWXicTziWfXf3yJ3B4e7O3q3e3RznNyJ663Fuj6aJHMV5Nz9wIgYpW9bPclJd9uWhX8Ae-TdwA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimal+strategies+for+COVID-19+prevention+from+global+evidence+achieved+through+social+distancing%2C+stay+at+home%2C+travel+restriction+and+lockdown%3A+a+systematic+review&rft.jtitle=Archives+of+public+health+%3D+Archives+belges+de+sant%C3%A9+publique&rft.au=Girum%2C+Tadele&rft.au=Kifle+Lentiro&rft.au=Geremew%2C+Mulugeta&rft.au=Migora%2C+Biru&rft.date=2021-08-21&rft.pub=BioMed+Central&rft.eissn=2049-3258&rft.volume=79&rft.spage=1&rft_id=info:doi/10.1186%2Fs13690-021-00663-8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2049-3258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2049-3258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2049-3258&client=summon